biOasis Technologies Inc. (the “Company”), (TSX.V: BTI) is pleased to announce that it has engaged the Anderson Forchung Group LLC (“Anderson Forchung”) of Washington, DC to develop a new SISCAPA Assay to measure the levels of p97 in human blood samples. Anderson Forschung is the developer of SISCAPA Assays, a new proteomics platform that allows […]

SAN DIEGO–Sequenom, Inc. (NASDAQ:SQNM – News), announced that breakthrough data from a collaborative project with The Chinese University of Hong Kong, supporting the noninvasive prenatal diagnosis of monogenic diseases, were published online today in the Early Edition of the Proceedings of the National Academy of Sciences. Monogenic diseases, which include cystic fibrosis, â-thalassemia and sickle […]

Canadian Physicians and Surgeons Can Now Diagnose MRSA and SA Skin and Soft Tissue Infections in Less Than One Hour, Leading to More Effective Treatment SUNNYVALE, Calif., Nov. 24 — Cepheid (Nasdaq: CPHD – News) today announced that Health Canada has issued a medical device license for its Xpert(TM) MRSA/SA Skin and Soft Tissue (SSTI) […]

AUSTIN, Texas & HONG KONG–Luminex Corporation (NASDAQ: LMNX – News), the worldwide leader in multiplexed solutions, and Mingyuan Medicare Development Company, a leading supplier of biomedical products in China, today announced the signing of a distribution and supply agreement. Under the terms of the agreement, Mingyuan will serve as the exclusive distributor in China and […]

QIAGEN’s Digene HPV Test Selected for World’s First National HPV Screening Program MEXICO CITY, Mexico, November 19 — In a campaign to significantly reduce the most common cancer affecting Mexican women, the Mexican Public Health Agency (Secretaria de Salud or SSA) has announced it is launching the first phase of a program that will offer […]

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that it has introduced its MGMT gene methylation assay using Methylation-Specific PCR technology licensed from OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA). Methylation of the MGMT gene promoter has been shown to be a common event in brain cancers and predictive of response to […]

Sequenom Completes Acquisition of CLIA-Certified Laboratory Monday November 17, 8:00 am ET SAN DIEGO–Sequenom (NASDAQ: SQNM – News) today announced that it has completed the previously announced acquisition of Grand Rapids, Michigan-based Center for Molecular Medicine, a Clinical Laboratory Improvement Act (CLIA) certified clinical diagnostics laboratory. As part of the acquisition, Sequenom has formalized certain […]

With more than 10 million new cases every year, cancer has become one of the world’s most devastating diseases, killing an estimated 20,000 people each day. To help meet the growing demand for treatment, the University of Pittsburgh Medical Center (UPMC) today announced collaboration with GE Healthcare, a unit of General Electric Company, to develop […]

Provista Life Sciences LLC (PLS) announced today that the National Health System’s Ethical Committee approval has been granted to proceed with a validation study of its Biomarker Translation Test (BT Test) in the United Kingdom (UK). The BT Test, a new blood test developed by Provista Life Sciences to aid healthcare providers in early breast […]

CENTER VALLEY, Pa. November 11, 2008 – Olympus America Inc. has signed an agreement with Thermo Fisher Scientific to enhance Olympus’ laboratory automation offerings to U.S. customers with a comprehensive open track automation solution for clinical laboratories. The new product offering will complement existing Olympus Lab Automation products including the OLA2500®. The agreement between the […]